Skip to main content
. 2020 Aug 18;12:73. doi: 10.1186/s13098-020-00580-w

Table 1.

Pre- and post-treatment characteristics among study groups

Variable Treatment Pre-treatment Post-treatment
Mean ± SD p value Mean ± SD p value
Age (years)c D 55.31 ± 8.85 0.889a NA
K 55.42 ± 12.62
D+K 57.08 ± 9.59
Alcohol consumptiond D 62.5 (10) 0.405b NA
K 41.7 (5)
D+K 66.7 (8)
Smokingd D 6.3 (1) 0.311b NA
K 25 (3)
D+K 25 (3)
Physical activityd D 50 (8) 0.574b NA
K 33.3 (4)
D+K 33.3 (4)
Weight (kg)c D 82.09 ± 18.16 0.670a 80.56 ± 16.58 0.775a
K 76.08 ± 20.86 75.80 ± 20.26
D+K 77.62 ± 15.64 78.58 ± 15.31
BMI (kg/m2)c D 30.23 ± 6.25 29.71 ± 5.93 0.770a
K 28.49 ± 7.44 28.38 ± 7.14
D+K 27.91 ± 4.55 0.586a 28.26 ± 4.42
Muscle (%)c D 51.38 ± 9.28 0.337a 51.29 ± 8.45 0.370a
K 46.01 ± 9.27 46.18 ± 10.00
D+K 50.48 ± 10.88 50.79 ± 11.69
Fat (%)c D 32.34 ± 10.69 0.875a 33.62 ± 9.74 0.795a
K 34.38 ± 9.89 34.78 ± 9.61
D+K 34.24 ± 14.67 31.98 ± 11.32
SBP (mmHg)c D 132.25 ± 16.60 0.870a 128.38 ± 16.13 0.914a
K 132.33 ± 27.19 130.17 ± 18.33
D+K 136.33 ± 23.18 126.92 ± 22.22
DBP (mmHg)c D 87.81 ± 13.49 0.252a 85.31 ± 14.85 0.138a
K 81.17 ± 14.14 78.17 ± 8.79
D+K 80.92 ± 8.35 76.67 ± 10.67
Glucose (mg/dL)c D 132.37 ± 18.71 0.627a 117.50 ± 17.50 0.520a
K 144.17 ± 35.76 130.25 ± 29.70
D+K 138.25 ± 40.65 123.58 ± 39.05
Insulin (ng/dL)c D 92.24 ± 50.13 0.603a 94.03 ± 49.89 0.363a
K 108.60 ± 54.59 85.17 ± 43.59
D+K 114.32 ± 76.68 113.75 ± 55.41
cOC (ng(dL)c D 0.809 ± 0.726 0.193a 0.986 ± 0.626 0.131a
K 0.818 ± 0.567 1.224 ± 1.092
D+K 0.441 ± 0.304 0.611 ± 0.278
uOC (ng/dL)c D 3.326 ± 1.774 0.097a 2.525 ± 1.566 0.754a
K 2.534 ± 1.616 2.355 ± 1.236
D+K 2.046 ± 1.010 2.136 ± 1.119
HOMA-IRc D 29.44 ± 14.99 0.333a 26.78 ± 13.30 0.406a
K 41.60 ± 28.22 28.66 ± 19.96
D+K 39.06 ± 25.39 35.84 ± 21.12
%FPβCc D 546.33 ± 427.38 0.776a 237.90 ± 89.21 0.301a
K 514.79 ± 204.01 174.21 ± 04.77
D+K 622.40 ± 444.25 281.51 ± 87.39
Cholesterol (mg/dL)c D 195.88 ± 36.73 0.801a 198.00 ± 48.66 0.789a
K 197.08 ± 41.52 206.08 ± 34.18
D+K 204.50 ± 25.94 194.92 ± 36.24
Triglycerides (mg/dL)c D 202.50 ± 142.56 0.856a 221.75 ± 115.46 0.155a
K 180.67 ± 115.08 188.08 ± 79.55
D+K 179.42 ± 106.34 154.83 ± 44.37
VLDL (mg/dL)c D 40.19 ± 28.78 0.875a 44.35 ± 23.09 0.155a
K 36.13 ± 23.02 37.62 ± 15.91
D+K 35.88 ± 21.27 30.97 ± 8.87

NA not applicable, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HOMA-IR homeostatic model assessment-insulin resistance,  % FPβC percentage of functional pancreatic beta cells, VLDL very low density lipoprotein, SD standard deviation

aMean values were compared using ANOVA test

bNumber of individuals were compared by Chi square test

cData presented as average and standard deviation

dData presented as percentage and number